Author

K. H. Gupta

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Zloza· 2 shared A. L. Marzo· 1 shared A. Morin· 1 shared B. Lyday· 1 shared E. F. Giurini· 1 shared G. Singh· 1 shared J. W. Goldfusky· 1 shared M. D. Willliams· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Zloza

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Attenuated Dengue Virus PV001-DV Induces Oncolytic Cell Death and Potent Anti-Tumor Immunity

A. L. Marzo, J. W. Goldfusky, P. Daniels, M. D. Willliams, K. H. Gupta, B. Lyday, T. Chen, G. Singh, A. Zloza

This study shows that PV001-DV, an attenuated Dengue virus, induces oncolytic cell death and activates anti-tumor immunity in melanoma and breast cancer cells.

bioRxiv · Jul 5, 2022 · PreprintCancer Biology

Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes

E. F. Giurini, M. Williams, A. Morin, A. Zloza, K. H. Gupta

This study shows that inactivated SARS-CoV-2 converts immunologically cold tumors to hot by generating CD8+ T cells, improving cancer outcomes in melanoma and triple-negative breast cancer.

bioRxiv · Jun 30, 2022 · PreprintCancer Biology